Deep Brain Stimulation Systems Market Segmentation, Scope And Forecast 2025 - 2034

Claim 20% Off With Code ONLINE20 – Explore Market Reports Covering Trade Trends, Regulatory Changes, and Growth Insights

What Is the Projected Growth Rate of the Deep Brain Stimulation Systems Market Through 2029?
The deep brain stimulation systems market size has grown strongly in recent years. It will grow from $2.53 billion in 2024 to $2.77 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to rising desire for less invasive operations among the general public, increasing demand for minimally invasive surgery in developed countries, rising demand for minimally invasive surgical procedures, high prevalence of diseases such as parkinson’s disease and epilepsy, increasing prevalence of neurological disorders.

The deep brain stimulation systems market size is expected to see rapid growth in the next few years. It will grow to $4.09 billion in 2029 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to increasing growth in the geriatric population, rising prevalence of neurological disorders globally, growing aging population, increasing acceptance of neurostimulation therapies, rising healthcare infrastructure development. Major trends in the forecast period include technological advancements in deep brain stimulation devices, advancements in technology, focus on non-motor symptoms, miniaturization and advanced materials, wireless connectivity and remote monitoring, multimodal therapies.

Claim your free report sample now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13834&type=smp

Which Drivers Are Positively Impacting the Deep Brain Stimulation Systems Market?
The increasing prevalence of neurological disorders is expected to propel the growth of the deep brain stimulation systems market going forward. Neurological disorders refer to a group of heterogeneous diseases that affect the body's autonomic, peripheral, and central nervous systems. Deep brain stimulation systems are used in neurosurgical procedures to send electrical stimulation to the desired area, aiming to alter or modulate neural functioning and achieve a reversible, adjustable, and therapeutic effect. For instance, in March 2023, according to the Parkinson's Foundation, a US-based national organization, nearly 90,000 people were diagnosed with PD every year in the US, a 50% increase from the previously estimated rate of 60,000 diagnoses annually. Therefore, the increasing prevalence of neurological disorders is driving the growth of the deep brain stimulation systems market.

Which Are the Leading Segments in the Deep Brain Stimulation Systems Market by Revenue?
The deep brain stimulation systemsmarket covered in this report is segmented –

1) By Product: Single Channel, Dual Channel
2) By Application: Parkinson's Disease, Essential Tremor, Obsessive Compulsive Disorder, Epilepsy, Dystonia, Other Applications
3) By End-user: Hospitals, Ambulatory Surgical Centers, Neurological Clinics, Other End Users

Which Trends Are Most Likely to Influence Deep Brain Stimulation Systems Market Growth in the Next Decade?
Major companies operating in the deep brain stimulation systems market are developing innovative technology, such as deep brain stimulation (DBS) systems, to treat patients with movement disorders. Deep Brain Stimulation (DBS) is a medical procedure that involves an implanted device that delivers an electrical current directly to areas of the brain. For instance, in January 2024, Abbott Laboratories, a US-based medical devices and health care company, launched the Liberta RC DBS system, the world's smallest rechargeable deep brain stimulation (DBS) device with remote programming, to treat people living with movement disorders. The Liberta RC DBS system is the only rechargeable, first-of-its-kind connected care technology in the U.S. and enables patients to stay in touch with their physicians, guarantee optimal configuration and operation, and obtain updated treatment settings remotely when necessary without having to visit a physician's office.

Who Are the Top Companies Contributing to the Deep Brain Stimulation Systems Market Expansion?
Major companies operating in the deep brain stimulation systems market report are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Quest Diagnostics Inc., St. Jude Medical Inc., Stanford Health Care, Associated Regional and University Pathologists Inc., LivaNova PLC, OPKO Health Inc., Nordic Laboratories, Myriad Genetics Inc., Nevro Corporation, Genomic Health, Mayo Medical Laboratories, Foundation Medicine Inc., SceneRay Co., ACM Global Laboratories, Neuropace Inc., American Esoteric Laboratories, Nexstim Oy, Aleva Neurotherapeutics S.A., NeuroSigma Inc., Beijing PINS Medical Co. Ltd., BioMONTR Labs, Functional Neuromodulation Ltd., Miraca Holdings Inc., Nuvectra Corporation

Get the full deep brain stimulation systems market report here:
https://www.thebusinessresearchcompany.com/report/deep-brain-stimulation-systems-global-market-report

How Are Market Trends Differentiating Across Key Regions in the Deep Brain Stimulation Systems Market?
North America was the largest region in the deep brain stimulation systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the deep brain stimulation systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company

https://thebusinessresearchcompany.com/

Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267

Email: info@tbrc.info


Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company